3Dバイオプリンティング市場 : 2029年までの世界予測

出版：MarketsandMarkets（マーケッツアンドマーケッツ）　出版年月：2024年5月

3D Bioprinting Market – Global Forecast to 2029

3Dバイオプリンティング市場 : コンポーネント [3D バイオプリンター (マイクロ押出、インクジェット、レーザー)、バイオインク、ソフトウェア、消耗品]、材料 (ヒドロゲル、ECM)、用途 [研究 (再生医療、3D 細胞培養)、臨床 (皮膚、骨)] – 2029年までの世界予測
3D Bioprinting Market by Component (3D bioprinters (Microextrusion, Inkjet, Laser), Bioinks, Software, Consumable), Material (Hydrogels, ECM), Application(Research (Regenerative Medicine, 3D cell Culture), Clinical (Skin, Bone)) – Global Forecast to 2029

[myphp file=”contact”]　　出版社・価格・納期について

Report Overview

The 3D bioprinting market is projected to reach USD 2.4 Billion by 2029 from USD 1.3 Billion in 2024, at a CAGR of 12.7% during the forecast period.

3Dバイオプリンティング市場は、予測期間中のCAGR 12.7%で、2024年の13億米ドルから2029年までに24億米ドルに達すると予測されています。

The 3D bioprinting market is driven by several key factors, including increasing collaborations between public and private entities and significant investments in research and development and growing interest in regenerative medicine and stem cell research.

“The 3D bioprinters segment held the dominant share in the 3D bioprinting market.”
Based on technology, the global 3D bioprinting market is segmented into 3D bioprinters, bioinks, software, and consumable. The 3D bioprinters is segmented into Microextrusion bioprinters, , inkjet 3D bioprinters, laser-assisted bioprinters, magnetic 3D bioprinters, stereolithography-based bioprinters, and other 3D bioprinters. The 3D bioprinters segment dominated the 3D bioprinting market in 2023. Advancements in 3D bioprinting technology and rising demand for organ transplants serves as driving factor in the 3D bioprinting market.

“Research application accounted for the largest share of the application in 2023.”
Based on application, the 3D bioprinting market is segmented into research application and clinical application. The research application is further segmented into regenerative medicine, 3D cell culture and drug research Also, the clinical application is segmented into bone & cartilage, blood vessels, skin and other clinical applications. In 2023, Research segment dominated the 3D bioprinting market. Research segment is anticipated to grow at significant CAGR during the forecast period of 2024-2028 owing to various factors such as biopharmaceuticals firms ramping up their utilization of 3D bioprinting technology.

“Asia Pacific region is likely to grow at a faster pace in the 3D bioprinting market.”
The 3D bioprinting market region is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and the Africa. The Asia-Pacific region is poised to experience significant growth in the 3D bioprinting market due to several key factors such as increasing healthcare expenditure in countries like China, India, and Southeast Asian nations region benefits from a significant population base and domestic system manufacturing, driving increased partnerships and collaborations aimed at healthcare improvement. With a high level of R&D intensity, market players are actively expanding their presence in the region, complemented by a surge in stem cell research, further stimulate market growth.

The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 70%, and Demand Side – 30%
• By Designation (Supply Side): Managers – 45%, CXOs & Directors – 30%, Executives- 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, Middle East-and Africa -5%

List of Companies Profiled in the Report:
• BICO Group AB (Sweden)
• 3D Systems Inc. (US)
• Merck KGaA (Germany)
• Organovo Holdings Inc (US)
• Collplant Biotechnologies Ltd. (Israel)
• regenHU (Switzerland)
• Aspect Biosystem Ltd. (Canada)
• Advanced Solutions Life Sciences, llc (US)
• Cyfuse Biomedical K.K (Japan)
• Rokit Healthcare Inc (South Korea)
• Hangzhou Genofei Biotechnology Co., Ltd. (China)
• Foldink (Armenia)
• Brinter (US)
• 3D bioprinting solution (Russia).
• REGEMAT 3D, SL (Spain)
• Ροietis (France)
• Sunp Biotech (US)
• GeSim – Gesellschaft Für Silizium-Mikrosysteme Mbh (Germany)
• Medprin (China)
• Voxcell Bioinnovation Inc. (Canada)
• Prodways (France)
• Inventia Life Science Pty Ltd (Australia)
• Upnano Gmbh (Austria)
• UPM (Finland)
• Tissuelabs (Switzerland)

Research Coverage:
This report provides a detailed picture of the vaccine market. It aims at estimating the size and future growth potential of the market across different segments such as the components, material, application, end-user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall 3D bioprinting market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:
• Analysis of key drivers (growing adoption of 3D bioprinting technology in the pharmaceutical and cosmetic industries, technological advancement in the 3D bioprinting , increasing number of public-private partnerships, rising investments in R&D and medical devices), opportunities (Rising demand for organ transplants and growing demand for regenerative medicine and stem cell research) and challenges (biocompatibility issues and rigorous sterilization protocols and ethical concerns related to the use of 3D bioprinted products) are influencing the growth of 3D bioprinting market.
• Product Development/Innovation: Detailed insights on newly launched products of the 3D bioprinting market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the 3D bioprinting market across varied regions.
• Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the 3D bioprinting market..
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players include BICO Group AB (Sweden), 3D Systems Inc. (US), Merck KGaA (Germany), Organovo Holdings Inc (US), Collplant Biotechnologies Ltd (Israel), regenHU (Switzerland), Aspect Biosystem (Canada), Advanced Solutions Life Sciences, llc (US), Cyfuse Biomedical K.K (Japan), Rokit Healthcare (South Korea), Hangzhou Genofei Biotechnology Co., Ltd. (China), Foldink (Armenia), Brinter (US) and 3D bioprinting solution (Russia).

Table of Contents

1            INTRODUCTION            37

1.1         STUDY OBJECTIVES      37

1.2         MARKET DEFINITION   37

1.2.1      INCLUSIONS AND EXCLUSIONS 38

1.3         STUDY SCOPE  38

1.3.1      SEGMENTS COVERED   38

FIGURE 1           3D BIOPRINTING MARKET: SEGMENTS COVERED          38

1.3.2      REGIONS COVERED      39

FIGURE 2           3D BIOPRINTING MARKET: REGIONS COVERED             39

1.3.3      YEARS CONSIDERED     39

1.3.4      CURRENCY CONSIDERED          40

1.4         RESEARCH LIMITATIONS           40

1.5         STAKEHOLDERS            40

1.6         SUMMARY OF CHANGES            41

1.6.1      RECESSION IMPACT      41

2            RESEARCH METHODOLOGY     42

2.1         RESEARCH DATA           42

FIGURE 3           RESEARCH DESIGN       42

2.1.1      SECONDARY DATA       43

2.1.2      PRIMARY DATA 44

2.1.2.1   Breakdown of primaries     44

FIGURE 4           BREAKDOWN OF PRIMARIES: 3D BIOPRINTING MARKET              44

2.2         MARKET SIZE ESTIMATION       45

FIGURE 5           3D BIOPRINTING MARKET SIZE ESTIMATION (SUPPLY SIDE ANALYSIS), 2023             45

FIGURE 6           MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION, 2023          46

FIGURE 7           ILLUSTRATIVE EXAMPLE OF BICO GROUP AB: REVENUE SHARE ANALYSIS (2023) 46

2.2.1      INSIGHTS FROM PRIMARY EXPERTS      48

FIGURE 8           MARKET VALIDATION FROM PRIMARY SOURCES           48

2.2.2      MARKET SIZE ESTIMATION, BY SEGMENT         49

FIGURE 9           MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH       49

2.3         GROWTH RATE ASSUMPTIONS 50

2.3.1      CAGR PROJECTIONS     50

FIGURE 10         3D BIOPRINTING MARKET: CAGR PROJECTIONS, 2024–2029              50

2.3.2      IMPACT OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS            51

TABLE 1             IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS           51

2.4         STUDY ASSUMPTIONS  51

2.5         MARKET BREAKDOWN AND DATA TRIANGULATION    52

FIGURE 11         DATA TRIANGULATION METHODOLOGY         52

2.6         RISK ANALYSIS 53

2.7         IMPACT OF ECONOMIC RECESSION ON 3D BIOPRINTING MARKET              53

3            EXECUTIVE SUMMARY 54

FIGURE 12         3D BIOPRINTING MARKET, BY COMPONENT 2024 VS. 2029 (USD MILLION) 54

FIGURE 13        3D BIOPRINTING MARKET, BY APPLICATION, BY TYPE, 2024 VS. 2029 (USD MILLION)     55

FIGURE 14         3D BIOPRINTING MARKET, BY MATERIAL, 2024 VS. 2029 (USD MILLION)          56

FIGURE 15         3D BIOPRINTING MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)          57

FIGURE 16         GEOGRAPHICAL SNAPSHOT OF 3D BIOPRINTING MARKET              58

4            PREMIUM INSIGHTS      59

4.1         3D BIOPRINTING MARKET OVERVIEW  59

FIGURE 17         RISING DEMAND FOR ORGAN TRANSPLANTS TO DRIVE MARKET            59

4.2         NORTH AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT AND COUNTRY (2023)           60

FIGURE 18         US AND 3D BIOPRINTERS ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 60

4.3         3D BIOPRINTING MARKET, BY COMPONENT, 2024 VS. 2029        61

FIGURE 19         3D BIOPRINTERS TO DOMINATE MARKET DURING STUDY PERIOD              61

4.4         3D BIOPRINTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES              62

FIGURE 20         ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD         62

5            MARKET OVERVIEW     63

5.1         INTRODUCTION            63

5.2         MARKET DYNAMICS     63

FIGURE 21         3D BIOPRINTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    63

5.2.1      DRIVERS            64

5.2.1.1   Growing adoption of 3D bioprinting in pharmaceutical and cosmetic industries              64

5.2.1.2   Technological advancements in 3D bioprinting            65

5.2.1.3   Increasing number of public-private partnerships        65

5.2.1.4   Rising investments in medical device R&D     66

5.2.2      RESTRAINTS     67

5.2.2.1   Risk of 3D bioprinting failures         67

5.2.2.2   High cost of 3D bioprinters and bioinks         68

5.2.3      OPPORTUNITIES           68

5.2.3.1   Rising demand for organ transplants 68

FIGURE 22         NUMBER OF ORGAN TRANSPLANTS IN US (2024)           69

5.2.3.2   Growing demand for regenerative medicine and stem cell research          69

5.2.4      CHALLENGES   70

5.2.4.1   Biocompatibility issues and rigorous sterilization protocols        70

5.2.4.2   Ethical concerns related to use of 3D-bioprinted products         71

5.3         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 72

FIGURE 23         REVENUE SHIFT TOWARDS 3D BIOPRINTING COMPANIES              72

5.4         TECHNOLOGY ANALYSIS           72

5.4.1      KEY TECHNOLOGIES    72

5.4.1.1   Extrusion-based bioprinting            72

5.4.1.2   Inkjet-based bioprinting     73

5.4.1.3   Stereolithography bioprinting          73

5.4.2      COMPLEMENTARY TECHNOLOGIES     73

5.4.2.1   Microfluidics and microfabrication  73

5.4.2.2   Nanotechnology and nanomaterials 73

5.4.3      ADJACENT TECHNOLOGIES      74

5.4.3.1   3D scanning and imaging   74

5.4.3.2   Organ-on-a-chip 74

5.4.3.3   Organoids technology        74

5.5         PRICING ANALYSIS        74

5.5.1      AVERAGE SELLING PRICE OF COMPONENTS, BY REGION           75

TABLE 2             3D BIOPRINTING MARKET: AVERAGE SELLING PRICE OF COMPONENTS, BY REGION, 2021–2023  75

5.6         VALUE CHAIN ANALYSIS            76

FIGURE 24         3D BIOPRINTING MARKET: VALUE CHAIN ANALYSIS     76

5.7         SUPPLY CHAIN ANALYSIS          77

FIGURE 25         3D BIOPRINTING MARKET: SUPPLY CHAIN ANALYSIS   77

TABLE 3             3D BIOPRINTING MARKET: ROLE IN SUPPLY CHAIN      79

5.8         ECOSYSTEM ANALYSIS 80

FIGURE 26         3D BIOPRINTING MARKET: ECOSYSTEM MAP   80

5.8.1      3D BIOPRINTER VENDORS         81

TABLE 4             3D BIOPRINTER VENDORS: ROLE IN ECOSYSTEM           81

5.8.2      BIOINK VENDORS          81

TABLE 5             BIOINK VENDORS: ROLE IN ECOSYSTEM            81

5.8.3      END USERS       82

TABLE 6             END USERS: ROLE IN ECOSYSTEM         82

5.8.4      REGULATORY BODIES  82

TABLE 7             REGULATORY BODIES: ROLE IN ECOSYSTEM    82

5.9         PATENT ANALYSIS        83

5.9.1      METHODOLOGY           83

5.9.2      NUMBER OF PATENTS APPLIED AND GRANTED, BY DOCUMENT TYPE, 2014–2024          83

TABLE 8             NUMBER OF PATENTS APPLIED AND GRANTED, 2014–2024              83

5.9.3      INNOVATION AND PATENT APPLICATION        83

FIGURE 27         NUMBER OF PATENTS GRANTED ANNUALLY, 2014–2024              84

5.9.4      TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS 84

FIGURE 28         TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2024         84

FIGURE 29         REGIONAL ANALYSIS OF PATENTS GRANTED, 2014–2024              85

TABLE 9             3D BIOPRINTING MARKET: TOP 12 PATENT OWNERS IN US, 2014–2024          85

TABLE 10           PATENTS IN 3D BIOPRINTING MARKET, 2023    86

5.10       TRADE ANALYSIS          89

5.10.1    IMPORT DATA FOR INK-JET PRINTING MACHINES (HS CODE: 844351)              89

TABLE 11           IMPORT VOLUME FOR INK-JET PRINTING MACHINES (HS CODE: 844351), 2019–2023 (TONS)           89

5.10.2    EXPORT DATA FOR INK-JET PRINTING MACHINES (HS CODE: 844351)              89

TABLE 12           EXPORT VOLUME FOR INK-JET PRINTING MACHINES (HS CODE: 844351), 2019–2023 (TONS)           89

5.10.3    IMPORT DATA FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE: 844339) 90

TABLE 13           IMPORT VOLUME FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE: 844339), 2019–2023 (USD)             90

5.10.4    EXPORT DATA FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE: 844339) 90

TABLE 14           EXPORT VOLUME FOR PRINTERS, COPYING MACHINES, AND FACSIMILE MACHINES, WHETHER OR NOT COMBINED (HS CODE-844339), 2019–2023 (USD)             90

5.11       KEY CONFERENCES AND EVENTS, 2024–2025     91

TABLE 15           3D BIOPRINTING MARKET: KEY CONFERENCES AND EVENTS              91

5.12       REGULATORY LANDSCAPE       92

5.12.1    CDRH REGULATIONS ON 3D BIOPRINTING       92

5.12.2    LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          92

TABLE 16           NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         92

TABLE 17           EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         93

TABLE 18           ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         94

TABLE 19           REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         95

5.13       INVESTMENT AND FUNDING SCENARIO            96

5.14       PORTER’S FIVE FORCES ANALYSIS         97

FIGURE 30         3D BIOPRINTING MARKET: PORTER’S FIVE FORCES ANALYSIS              97

TABLE 20           3D BIOPRINTING MARKET: PORTER’S FIVE FORCES ANALYSIS              97

5.14.1    THREAT OF NEW ENTRANTS    98

5.14.2    THREAT OF SUBSTITUTES         98

5.14.3    BARGAINING POWER OF BUYERS           98

5.14.4    BARGAINING POWER OF SUPPLIERS     98

5.14.5    INTENSITY OF COMPETITIVE RIVALRY 98

5.15       KEY STAKEHOLDERS AND BUYING CRITERIA    98

5.15.1    KEY STAKEHOLDERS IN BUYING PROCESS         99

TABLE 21           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS             99

5.15.2    KEY BUYING CRITERIA 100

5.15.2.1 Key buying criteria for top three end users     100

TABLE 22           KEY BUYING CRITERIA FOR TOP THREE END USERS IN 3D BIOPRINTERS MARKET 100

6            3D BIOPRINTING MARKET, BY COMPONENT    102

6.1         INTRODUCTION            103

TABLE 23           3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)          103

6.2         3D BIOPRINTERS           103

TABLE 24           3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)          104

TABLE 25           3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY REGION, 2022–2029 (USD MILLION)          104

TABLE 26           NORTH AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION) 105

TABLE 27           EUROPE: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION)    105

TABLE 28          ASIA PACIFIC: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION)            106

TABLE 29           LATIN AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION) 106

TABLE 30           MIDDLE EAST: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION) 107

TABLE 31           GCC COUNTRIES: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY COUNTRY, 2022–2029 (USD MILLION) 107

6.2.1      MICRO EXTRUSION BIOPRINTERS          107

6.2.1.1   Adaptability to different biomaterial types to fuel segment growth           107

TABLE 32           MICRO EXTRUSION BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)     108

TABLE 33           NORTH AMERICA: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            109

TABLE 34           EUROPE: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    109

TABLE 35           ASIA PACIFIC: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    110

TABLE 36           LATIN AMERICA: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            110

TABLE 37           MIDDLE EAST: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    111

TABLE 38           GCC COUNTRIES: MICRO EXTRUSION BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            111

6.2.2      INKJET 3D BIOPRINTERS            111

6.2.2.1   High cell viability and low cost to propel market growth             111

TABLE 39           INKJET 3D BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)          112

TABLE 40           NORTH AMERICA: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    112

TABLE 41           EUROPE: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          113

TABLE 42          ASIA PACIFIC: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          113

TABLE 43           LATIN AMERICA: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    114

TABLE 44           MIDDLE EAST: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    114

TABLE 45           GCC COUNTRIES: INKJET 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    115

6.2.3      LASER-ASSISTED BIOPRINTERS 115

6.2.3.1   Higher resolution and better formation of 3D structures to augment segment growth   115

TABLE 46           LASER-ASSISTED BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)     116

TABLE 47           NORTH AMERICA: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    116

TABLE 48           EUROPE: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    117

TABLE 49           ASIA PACIFIC: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    117

TABLE 50           LATIN AMERICA: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    118

TABLE 51           MIDDLE EAST: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    118

TABLE 52           GCC COUNTRIES: LASER-ASSISTED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    119

6.2.4      STEREOLITHOGRAPHY-BASED BIOPRINTERS   119

6.2.4.1   Better printing quality, speed, and cell viability to aid growth     119

TABLE 53           STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)       120

TABLE 54           NORTH AMERICA: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)           120

TABLE 55           EUROPE: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         121

TABLE 56           ASIA PACIFIC: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         121

TABLE 57           LATIN AMERICA: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         122

TABLE 58           MIDDLE EAST: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         122

TABLE 59           GCC COUNTRIES: STEREOLITHOGRAPHY-BASED BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)           123

6.2.5      MAGNETIC 3D BIOPRINTERS    123

6.2.5.1   Improved accuracy and speed in cultured tissue formation and processing to fuel segment growth   123

TABLE 60           MAGNETIC 3D BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 124

TABLE 61           NORTH AMERICA: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    124

TABLE 62           EUROPE: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          125

TABLE 63           ASIA PACIFIC: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    125

TABLE 64           LATIN AMERICA: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    126

TABLE 65           MIDDLE EAST: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    126

TABLE 66           GCC COUNTRIES: MAGNETIC 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    127

6.2.6      OTHER 3D BIOPRINTERS           127

TABLE 67           OTHER 3D BIOPRINTERS MARKET, BY REGION, 2022–2029 (USD MILLION)          128

TABLE 68           NORTH AMERICA: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    128

TABLE 69           EUROPE: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          129

TABLE 70          ASIA PACIFIC: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          129

TABLE 71           LATIN AMERICA: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    130

TABLE 72           MIDDLE EAST: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    130

TABLE 73           GCC COUNTRIES: OTHER 3D BIOPRINTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    131

6.3         BIOINKS             131

TABLE 74           3D BIOPRINTERS MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION) 132

TABLE 75           3D BIOPRINTING MARKET FOR BIOINKS, BY REGION, 2022–2029 (USD MILLION)     132

TABLE 76           NORTH AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)    133

TABLE 77           EUROPE: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)    133

TABLE 78           ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)    134

TABLE 79           LATIN AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)    134

TABLE 80           MIDDLE EAST: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)    135

TABLE 81           GCC COUNTRIES: 3D BIOPRINTING MARKET FOR BIOINKS, BY COUNTRY, 2022–2029 (USD MILLION)    135

6.3.1      NATURAL BIOINKS        136

6.3.1.1   Increasing investment in R&D and product developments to drive market              136

TABLE 82           NATURAL BIOINKS MARKET, BY REGION, 2022–2029 (USD MILLION)          136

TABLE 83           NORTH AMERICA: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          137

TABLE 84           EUROPE: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 137

TABLE 85           ASIA PACIFIC: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          138

TABLE 86           LATIN AMERICA: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          138

TABLE 87           MIDDLE EAST: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          139

TABLE 88           GCC COUNTRIES: NATURAL BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          139

6.3.2      HYBRID BIOINKS            139

6.3.2.1   Higher mechanical strength and greater biocompatibility to boost segment growth              139

TABLE 89           HYBRID BIOINKS MARKET, BY REGION, 2022–2029 (USD MILLION)          140

TABLE 90           NORTH AMERICA: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          140

TABLE 91           EUROPE: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 141

TABLE 92           ASIA PACIFIC: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     141

TABLE 93           LATIN AMERICA: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          142

TABLE 94           MIDDLE EAST: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     142

TABLE 95           GCC COUNTRIES: HYBRID BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          143

6.3.3      SYNTHETIC BIOINKS     143

6.3.3.1   Flexibility, control, and consistency to aid segment growth         143

TABLE 96           SYNTHETIC BIOINKS MARKET, BY REGION, 2022–2029 (USD MILLION)          144

TABLE 97           NORTH AMERICA: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    144

TABLE 98           EUROPE: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     145

TABLE 99           ASIA PACIFIC: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          145

TABLE 100         LATIN AMERICA: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          146

TABLE 101         MIDDLE EAST: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          146

TABLE 102        GCC COUNTRIES: SYNTHETIC BIOINKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          147

6.4         SOFTWARE       147

6.4.1      INCREASING INNOVATIONS AND ADVANCEMENTS TO PROPEL SEGMENT GROWTH     147

TABLE 103         3D BIOPRINTING MARKET FOR SOFTWARE, BY REGION, 2022–2029 (USD MILLION)     148

TABLE 104         NORTH AMERICA: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)            148

TABLE 105         EUROPE: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)    149

TABLE 106         ASIA PACIFIC: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)    149

TABLE 107         LATIN AMERICA: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)            150

TABLE 108         MIDDLE EAST: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)    150

TABLE 109         GCC COUNTRIES: 3D BIOPRINTING MARKET FOR SOFTWARE, BY COUNTRY, 2022–2029 (USD MILLION)            151

6.5         CONSUMABLES 151

6.5.1      NEED FOR PRECISE BIOINK DEPOSITION FOR INTRICATE TISSUE STRUCTURES TO DRIVE MARKET          151

TABLE 110         3D BIOPRINTING MARKET FOR CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)          152

TABLE 111         NORTH AMERICA: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)          152

TABLE 112         EUROPE: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)    153

TABLE 113         ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)            153

TABLE 114         LATIN AMERICA: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)          154

TABLE 115        MIDDLE EAST: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)            154

TABLE 116         GCC COUNTRIES: 3D BIOPRINTING MARKET FOR CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)          155

7            3D BIOPRINTING MARKET, BY MATERIAL          156

7.1         INTRODUCTION            157

TABLE 117         3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)          157

7.2         LIVING CELLS  157

7.2.1      INCREASED VIABILITY AND TECHNOLOGICAL ADVANCEMENTS TO AUGMENT MARKET GROWTH  157

TABLE 118         3D BIOPRINTING MARKET FOR LIVING CELLS, BY REGION, 2022–2029 (USD MILLION)          158

TABLE 119         NORTH AMERICA: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)             159

TABLE 120         EUROPE: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)    159

TABLE 121         ASIA PACIFIC: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)            160

TABLE 122         LATIN AMERICA: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)             160

TABLE 123         MIDDLE EAST: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)            161

TABLE 124         GCC COUNTRIES: 3D BIOPRINTING MARKET FOR LIVING CELLS, BY COUNTRY, 2022–2029 (USD MILLION)             161

7.3         HYDROGELS     161

7.3.1      INCREASING INVESTMENTS AND FUNDING TO BOOST MARKET GROWTH          161

TABLE 125         3D BIOPRINTING MARKET FOR HYDROGELS, BY REGION, 2022–2029 (USD MILLION)          162

TABLE 126         NORTH AMERICA: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION) 163

TABLE 127         EUROPE: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)    163

TABLE 128         ASIA PACIFIC: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)    164

TABLE 129         LATIN AMERICA: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)            164

TABLE 130         MIDDLE EAST: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)            165

TABLE 131        GCC COUNTRIES: 3D BIOPRINTING MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)            165

7.4         EXTRACELLULAR MATRICES    165

7.4.1      INCREASED FOCUS ON R&D AND ADVANCEMENTS IN TISSUE ENGINEERING TO SUPPORT MARKET GROWTH             165

TABLE 132         3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY REGION, 2022–2029 (USD MILLION)  166

TABLE 133         NORTH AMERICA: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION) 167

TABLE 134         EUROPE: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION)     167

TABLE 135         ASIA PACIFIC: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION) 168

TABLE 136         LATIN AMERICA: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION) 168

TABLE 137         MIDDLE EAST: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION) 169

TABLE 138         GCC COUNTRIES: 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES, BY COUNTRY, 2022–2029 (USD MILLION) 169

7.5         OTHER MATERIALS      170

TABLE 139         3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY REGION, 2022–2029 (USD MILLION)       171

TABLE 140         NORTH AMERICA: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)   171

TABLE 141         EUROPE: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)            172

TABLE 142         ASIA PACIFIC: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)   172

TABLE 143         LATIN AMERICA: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)   173

TABLE 144         MIDDLE EAST: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)   173

TABLE 145         GCC COUNTRIES: 3D BIOPRINTING MARKET FOR OTHER MATERIALS, BY COUNTRY, 2022–2029 (USD MILLION)   174

8            3D BIOPRINTING MARKET, BY APPLICATION    175

8.1         INTRODUCTION            176

TABLE 146         3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          176

8.2         RESEARCH APPLICATIONS        176

TABLE 147         3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)             177

TABLE 148         3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)       177

TABLE 149         NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           178

TABLE 150         EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           178

TABLE 151         ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           179

TABLE 152         LATIN AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           179

TABLE 153         MIDDLE EAST: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           180

TABLE 154         GCC COUNTRIES: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           180

8.2.1      DRUG RESEARCH          180

8.2.1.1   Better precision and greater customization facilities in pharmaceutical sector to drive segment      180

TABLE 155         DRUG RESEARCH MARKET, BY REGION, 2022–2029 (USD MILLION)          182

TABLE 156         NORTH AMERICA: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          182

TABLE 157         EUROPE: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 183

TABLE 158         ASIA PACIFIC: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     183

TABLE 159         LATIN AMERICA: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          184

TABLE 160         MIDDLE EAST: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     184

TABLE 161         GCC COUNTRIES: DRUG RESEARCH MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          184

8.2.2      REGENERATIVE MEDICINE        185

8.2.2.1   Growing demand for organ transplants to support segment growth          185

TABLE 162         REGENERATIVE MEDICINE MARKET, BY REGION, 2022–2029 (USD MILLION) 186

TABLE 163         NORTH AMERICA: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    186

TABLE 164         EUROPE: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          187

TABLE 165         ASIA PACIFIC: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    187

TABLE 166         LATIN AMERICA: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    188

TABLE 167         MIDDLE EAST: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    188

TABLE 168         GCC COUNTRIES: REGENERATIVE MEDICINE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    189

8.2.3      3D CELL CULTURE        189

8.2.3.1   Rising investments in cell culture development to augment segment growth              189

TABLE 169         3D CELL CULTURE MARKET, BY REGION, 2022–2029 (USD MILLION)          190

TABLE 170         NORTH AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          190

TABLE 171         EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 191

TABLE 172         ASIA PACIFIC: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          191

TABLE 173         LATIN AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          192

TABLE 174         MIDDLE EAST: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          192

TABLE 175         GCC COUNTRIES: 3D CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          192

8.3         CLINICAL APPLICATIONS          193

TABLE 176         3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)             193

TABLE 177         3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)       194

TABLE 178         NORTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           194

TABLE 179         EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           195

TABLE 180         ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           195

TABLE 181         LATIN AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           196

TABLE 182         MIDDLE EAST: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           196

TABLE 183         GCC COUNTRIES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           197

8.3.1      SKIN     197

8.3.1.1   Rising applications in skincare and cosmetics to propel segment growth   197

TABLE 184         SKIN MARKET, BY REGION, 2022–2029 (USD MILLION)   198

TABLE 185         NORTH AMERICA: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 198

TABLE 186         EUROPE: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          199

TABLE 187         ASIA PACIFIC: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          199

TABLE 188         LATIN AMERICA: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          200

TABLE 189         MIDDLE EAST: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          200

TABLE 190         GCC COUNTRIES: SKIN MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          200

8.3.2      BONE & CARTILAGE     201

8.3.2.1   Increasing incidence of musculoskeletal conditions to support segment growth              201

TABLE 191         BONE & CARTILAGE MARKET, BY REGION, 2022–2029 (USD MILLION)          202

TABLE 192        NORTH AMERICA: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          202

TABLE 193         EUROPE: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     203

TABLE 194         ASIA PACIFIC: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          203

TABLE 195         LATIN AMERICA: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          204

TABLE 196         MIDDLE EAST: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          204

TABLE 197         GCC COUNTRIES: BONE & CARTILAGE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          204

8.3.3      BLOOD VESSELS            205

8.3.3.1   Growing focus on research activities to aid segment growth       205

TABLE 198         BLOOD VESSELS MARKET, BY REGION, 2022–2029 (USD MILLION)          205

TABLE 199         NORTH AMERICA: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          206

TABLE 200         EUROPE: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 206

TABLE 201         ASIA PACIFIC: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     207

TABLE 202         LATIN AMERICA: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          207

TABLE 203         MIDDLE EAST: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     208

TABLE 204         GCC COUNTRIES: BLOOD VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          208

8.3.4      OTHER CLINICAL APPLICATIONS          208

TABLE 205         OTHER CLINICAL APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION)     209

TABLE 206         NORTH AMERICA: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            210

TABLE 207         EUROPE: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    210

TABLE 208         ASIA PACIFIC: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    211

TABLE 209         LATIN AMERICA: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            211

TABLE 210         MIDDLE EAST: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    212

TABLE 211         GCC COUNTRIES: OTHER CLINICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            212

9            3D BIOPRINTING MARKET, BY END USER           213

9.1         INTRODUCTION            214

TABLE 212         3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)          214

9.2         ACADEMIC & RESEARCH INSTITUTES   214

9.2.1      RISING GOVERNMENT FUNDING AND INCREASING NUMBER OF INDUSTRY-ACADEMIA COLLABORATIONS TO DRIVE MARKET 214

TABLE 213         3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)      215

TABLE 214         NORTH AMERICA: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)       216

TABLE 215         EUROPE: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)          216

TABLE 216         ASIA PACIFIC: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)          217

TABLE 217         LATIN AMERICA: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)          217

TABLE 218         MIDDLE EAST: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)          218

TABLE 219         GCC COUNTRIES: 3D BIOPRINTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)       218

9.3         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES   219

9.3.1      INCREASING PREVALENCE OF CHRONIC DISEASES TO PROPEL MARKET GROWTH        219

TABLE 220         3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 220

TABLE 221         NORTH AMERICA: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 220

TABLE 222         EUROPE: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)              221

TABLE 223         ASIA PACIFIC: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 221

TABLE 224         LATIN AMERICA: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 222

TABLE 225         MIDDLE EAST: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 222

TABLE 226         GCC COUNTRIES: 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 223

9.4         HOSPITALS       223

9.4.1      RISING NUMBER OF STRATEGIC PARTNERSHIPS WITH BIOTECHNOLOGY COMPANIES TO AID MARKET GROWTH       223

TABLE 227         3D BIOPRINTING MARKET FOR HOSPITALS, BY REGION, 2022–2029 (USD MILLION)     224

TABLE 228         NORTH AMERICA: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)            224

TABLE 229         EUROPE: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)    225

TABLE 230         ASIA PACIFIC: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)    225

TABLE 231         LATIN AMERICA: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)            226

TABLE 232         MIDDLE EAST: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)    226

TABLE 233         GCC COUNTRIES: 3D BIOPRINTING MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)            227

10          3D BIOPRINTING MARKET, BY REGION 228

10.1       INTRODUCTION            229

TABLE 234         3D BIOPRINTING MARKET, BY REGION, 2022–2029 (USD MILLION)          229

10.2       NORTH AMERICA          230

FIGURE 31         NORTH AMERICA: 3D BIOPRINTING MARKET SNAPSHOT              230

TABLE 235         NORTH AMERICA: 3D BIOPRINTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          231

TABLE 236         NORTH AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)           231

TABLE 237         NORTH AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)        232

TABLE 238         NORTH AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)             232

TABLE 239         NORTH AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)          233

TABLE 240         NORTH AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           233

TABLE 241         NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      234

TABLE 242         NORTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      234

TABLE 243         NORTH AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)          235

10.2.1    NORTH AMERICA: RECESSION IMPACT 235

10.2.2    US         235

10.2.2.1 US to dominate North American 3D bioprinting market during forecast period              235

TABLE 244         US: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 237

TABLE 245         US: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)          237

TABLE 246         US: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)     238

TABLE 247         US: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)          238

TABLE 248         US: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 239

TABLE 249         US: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       239

TABLE 250         US: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       240

TABLE 251         US: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)          240

10.2.3    CANADA            241

10.2.3.1 Increased number of public-private partnerships for life science research to drive market   241

TABLE 252         CANADA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)     241

TABLE 253         CANADA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)             242

TABLE 254         CANADA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)          242

TABLE 255         CANADA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 243

TABLE 256         CANADA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     243

TABLE 257         CANADA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      244

TABLE 258         CANADA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      244

TABLE 259         CANADA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION) 245

10.3       EUROPE             245

TABLE 260         EUROPE: 3D BIOPRINTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 246

TABLE 261         EUROPE: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)     246

TABLE 262         EUROPE: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)             247

TABLE 263         EUROPE: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)          247

TABLE 264         EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 248

TABLE 265         EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     248

TABLE 266         EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      249

TABLE 267         EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      249

TABLE 268         EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION) 250

10.3.1    EUROPE: RECESSION IMPACT   250

10.3.2    GERMANY         250

10.3.2.1 Rising healthcare expenditure and increasing demand for organ transplants to favor market growth           250

TABLE 269         GERMANY: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)     251

TABLE 270         GERMANY: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)       252

TABLE 271         GERMANY: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)          252

TABLE 272         GERMANY: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)     253

TABLE 273         GERMANY: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     253

TABLE 274         GERMANY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      254

TABLE 275         GERMANY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      254

TABLE 276         GERMANY: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION) 255

10.3.3    UK         255

10.3.3.1 Rising prevalence of chronic diseases and increasing R&D activities to drive market   255

TABLE 277         UK: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 256

TABLE 278         UK: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)          256

TABLE 279         UK: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)     257

TABLE 280         UK: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)          257

TABLE 281         UK: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 258

TABLE 282         UK: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       258

TABLE 283         UK: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       259

TABLE 284         UK: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)          259

10.3.4    FRANCE             259

10.3.4.1 Increasing availability of advanced medical technologies to support market growth              259

TABLE 285         FRANCE: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)     260

TABLE 286         FRANCE: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)             261

TABLE 287         FRANCE: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)          261

TABLE 288         FRANCE: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 262

TABLE 289         FRANCE: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     262

TABLE 290         FRANCE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      263

TABLE 291         FRANCE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      263

TABLE 292         FRANCE: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION) 264

10.3.5    ITALY   264

10.3.5.1 Increased research investment and funding to support market growth      264

TABLE 293         ITALY: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 265

TABLE 294         ITALY: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)             265

TABLE 295         ITALY: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)     266

TABLE 296         ITALY: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 266

TABLE 297         ITALY: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 267

TABLE 298         ITALY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      267

TABLE 299         ITALY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      268

TABLE 300         ITALY: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION) 268

10.3.6    SPAIN   269

10.3.6.1 Favorable investment scenario and increase in number of research centers to aid market growth     269

TABLE 301         SPAIN: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 269

TABLE 302         SPAIN: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)             270

TABLE 303         SPAIN: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)     270

TABLE 304         SPAIN: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 271

TABLE 305         SPAIN: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 271

TABLE 306         SPAIN: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      272

TABLE 307         SPAIN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      272

TABLE 308         SPAIN: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION) 273

10.3.7    REST OF EUROPE           273

TABLE 309        REST OF EUROPE: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)          274

TABLE 310         REST OF EUROPE: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)        274

TABLE 311         REST OF EUROPE: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)             275

TABLE 312         REST OF EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)          275

TABLE 313         REST OF EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           276

TABLE 314         REST OF EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      276

TABLE 315         REST OF EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      277

TABLE 316         REST OF EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)          277

10.4       ASIA PACIFIC    278

FIGURE 32         ASIA PACIFIC: 3D BIOPRINTING MARKET SNAPSHOT    279

TABLE 317         ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     280

TABLE 318         ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)          280

TABLE 319        ASIA PACIFIC: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)       281

TABLE 320         ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)             281

TABLE 321         ASIA PACIFIC: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)     282

TABLE 322         ASIA PACIFIC: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          282

TABLE 323         ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      283

TABLE 324         ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      283

TABLE 325         ASIA PACIFIC: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)     284

10.4.1    CHINA  284

10.4.1.1 Increasing government focus on pharmaceutical R&D and growing demand for organ transplants to augment market growth 284

TABLE 326         CHINA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 285

TABLE 327         CHINA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)             285

TABLE 328         CHINA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)          286

TABLE 329         CHINA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 286

TABLE 330         CHINA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     287

TABLE 331         CHINA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      287

TABLE 332         CHINA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      288

TABLE 333         CHINA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION) 288

10.4.2    JAPAN  289

10.4.2.1 Advancements in healthcare infrastructure to support market growth      289

TABLE 334         JAPAN: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 289

TABLE 335         JAPAN: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)             290

TABLE 336         JAPAN: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)          290

TABLE 337         JAPAN: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 291

TABLE 338         JAPAN: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 291

TABLE 339         JAPAN: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      292

TABLE 340         JAPAN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      292

TABLE 341         JAPAN: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION) 293

10.4.3    INDIA   293

10.4.3.1 Increasing developments in biopharmaceutical industry to propel market growth              293

TABLE 342         INDIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION) 294

TABLE 343         INDIA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)             294

TABLE 344         INDIA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)     295

TABLE 345         INDIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 295

TABLE 346         INDIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 296

TABLE 347         INDIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      296

TABLE 348         INDIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      297

TABLE 349         INDIA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION) 297

10.4.4    AUSTRALIA       298

10.4.4.1 Rising private and public funding for research activities to drive market   298

TABLE 350         AUSTRALIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)          298

TABLE 351         AUSTRALIA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)       299

TABLE 352         AUSTRALIA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)          299

TABLE 353         AUSTRALIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)     300

TABLE 354         AUSTRALIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          300

TABLE 355         AUSTRALIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      301

TABLE 356         AUSTRALIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      301

TABLE 357         AUSTRALIA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)     302

10.4.5    SOUTH KOREA 302

10.4.5.1 Favorable government policies and high investments from private sector to fuel market growth     302

TABLE 358         SOUTH KOREA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)          303

TABLE 359         SOUTH KOREA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)        303

TABLE 360         SOUTH KOREA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)             304

TABLE 361         SOUTH KOREA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)          304

TABLE 362         SOUTH KOREA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          305

TABLE 363         SOUTH KOREA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      305

TABLE 364         SOUTH KOREA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      306

TABLE 365         SOUTH KOREA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)          306

10.4.6    REST OF ASIA PACIFIC  307

10.4.7    ASIA PACIFIC: RECESSION IMPACT        307

TABLE 366         REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)           308

TABLE 367         REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)        308

TABLE 368         REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)    309

TABLE 369         REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)   309

TABLE 370         REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           310

TABLE 371         REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 310

TABLE 372         REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  311

TABLE 373         REST OF ASIA PACIFIC: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)             311

10.5       LATIN AMERICA             312

TABLE 374         LATIN AMERICA: 3D BIOPRINTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          312

TABLE 375         LATIN AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)          312

TABLE 376         LATIN AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)        313

TABLE 377         LATIN AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)             313

TABLE 378         LATIN AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)          314

TABLE 379         LATIN AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          314

TABLE 380         LATIN AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      315

TABLE 381         LATIN AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      315

TABLE 382         LATIN AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)          316

10.5.1    LATIN AMERICA: RECESSION IMPACT   316

10.5.2    BRAZIL 317

10.5.2.1 Brazil to hold largest share in Latin American market  317

TABLE 383         BRAZIL: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)     317

TABLE 384         BRAZIL: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)             318

TABLE 385         BRAZIL: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)          318

TABLE 386         BRAZIL: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 319

TABLE 387         BRAZIL: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     319

TABLE 388         BRAZIL: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      320

TABLE 389         BRAZIL: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      320

TABLE 390         BRAZIL: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION) 321

10.5.3    MEXICO             321

10.5.3.1 Increasing incidence of diabetes and growing geriatric population to aid market growth   321

TABLE 391         MEXICO: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)     322

TABLE 392         MEXICO: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)             322

TABLE 393         MEXICO: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)          323

TABLE 394         MEXICO: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 323

TABLE 395         MEXICO: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     324

TABLE 396         MEXICO: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      324

TABLE 397         MEXICO: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      325

TABLE 398         MEXICO: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION) 325

10.5.4    REST OF LATIN AMERICA          326

TABLE 399         REST OF LATIN AMERICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)           326

TABLE 400         REST OF LATIN AMERICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)        327

TABLE 401         REST OF LATIN AMERICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)    327

TABLE 402         REST OF LATIN AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)   328

TABLE 403         REST OF LATIN AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           328

TABLE 404         REST OF LATIN AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 329

TABLE 405         REST OF LATIN AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  329

TABLE 406         REST OF LATIN AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)             330

10.6       MIDDLE EAST  330

TABLE 407         MIDDLE EAST: 3D BIOPRINTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     330

TABLE 408         MIDDLE EAST: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)          331

TABLE 409         MIDDLE EAST: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)        331

TABLE 410         MIDDLE EAST: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)             332

TABLE 411         MIDDLE EAST: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)     332

TABLE 412         MIDDLE EAST: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          333

TABLE 413         MIDDLE EAST: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      333

TABLE 414         MIDDLE EAST: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      334

TABLE 415         MIDDLE EAST: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)     334

10.6.1    MIDDLE EAST: RECESSION IMPACT       334

10.6.2    GCC COUNTRIES           335

TABLE 416         GCC COUNTRIES: 3D BIOPRINTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          335

TABLE 417        GCC COUNTRIES: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)          335

TABLE 418         GCC COUNTRIES: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)        336

TABLE 419         GCC COUNTRIES: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)             336

TABLE 420         GCC COUNTRIES: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)          337

TABLE 421         GCC COUNTRIES: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           337

TABLE 422         GCC COUNTRIES: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      338

TABLE 423         GCC COUNTRIES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      338

TABLE 424         GCC COUNTRIES: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)          339

10.6.2.1 Saudi Arabia        339

10.6.2.1.1            Increasing government investments in healthcare and growing pharmaceuticals industry to support market growth     339

TABLE 425         SAUDI ARABIA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)          340

TABLE 426         SAUDI ARABIA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)        340

TABLE 427         SAUDI ARABIA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)             341

TABLE 428         SAUDI ARABIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)          341

TABLE 429         SAUDI ARABIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          342

TABLE 430         SAUDI ARABIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      342

TABLE 431         SAUDI ARABIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      343

TABLE 432         SAUDI ARABIA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)     343

10.6.2.2 United Arab Emirates        344

10.6.2.2.1            Increased R&D expenditure and advanced healthcare infrastructure to boost market growth          344

TABLE 433         UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)           344

TABLE 434         UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)        345

TABLE 435         UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)    345

TABLE 436         UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)   346

TABLE 437         UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           346

TABLE 438         UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 347

TABLE 439         UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  347

TABLE 440         UNITED ARAB EMIRATES: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)             348

10.6.2.3 Rest of GCC countries       348

TABLE 441         REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)           349

TABLE 442         REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)        349

TABLE 443         REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)    350

TABLE 444         REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)   350

TABLE 445         REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           351

TABLE 446         REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 351

TABLE 447         REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  352

TABLE 448         REST OF GCC COUNTRIES: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)             352

10.6.3    REST OF MIDDLE EAST 353

TABLE 449         REST OF MIDDLE EAST: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)           353

TABLE 450         REST OF MIDDLE EAST: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)        354

TABLE 451         REST OF MIDDLE EAST: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)    354

TABLE 452         REST OF MIDDLE EAST: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION)   355

TABLE 453         REST OF MIDDLE EAST: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           355

TABLE 454         REST OF MIDDLE EAST: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION) 356

TABLE 455         REST OF MIDDLE EAST: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)  356

TABLE 456         REST OF MIDDLE EAST: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION)             357

10.7       AFRICA 357

10.7.1    GROWING FOCUS ON FUNDING AND PARTNERSHIPS IN RESEARCH SECTOR TO AID MARKET GROWTH      357

TABLE 457         AFRICA: 3D BIOPRINTING MARKET, BY COMPONENT, 2022–2029 (USD MILLION)     358

TABLE 458         AFRICA: 3D BIOPRINTING MARKET FOR 3D BIOPRINTERS, BY TYPE, 2022–2029 (USD MILLION)             358

TABLE 459         AFRICA: 3D BIOPRINTING MARKET FOR BIOINKS, BY TYPE, 2022–2029 (USD MILLION)          359

TABLE 460         AFRICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 359

TABLE 461         AFRICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     360

TABLE 462         AFRICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      360

TABLE 463         AFRICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      361

TABLE 464         AFRICA: 3D BIOPRINTING MARKET, BY END USER, 2022–2029 (USD MILLION) 361

10.7.2    AFRICA: RECESSION IMPACT     361

11          COMPETITIVE LANDSCAPE       362

11.1       INTRODUCTION            362

11.2       KEY STRATEGIES/RIGHT TO WIN           362

FIGURE 33         3D BIOPRINTING MARKET: STRATEGIES ADOPTED       362

11.3       REVENUE ANALYSIS      363

FIGURE 34         REVENUE ANALYSIS OF KEY PLAYERS (2021–2023)          363

11.4       MARKET SHARE ANALYSIS         364

FIGURE 35         MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)        364

TABLE 465         3D BIOPRINTING MARKET: DEGREE OF COMPETITION 365

11.5       COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023   366

11.5.1    STARS  366

11.5.2    EMERGING LEADERS    366

11.5.3    PERVASIVE PLAYERS     366

11.5.4    PARTICIPANTS 367

FIGURE 36         3D BIOPRINTING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023     367

11.5.5    COMPANY FOOTPRINT: KEY PLAYERS, 2023      368

11.5.5.1 Overall footprint  368

FIGURE 37         3D BIOPRINTING MARKET: OVERALL FOOTPRINT         368

11.5.5.2 Component footprint         369

TABLE 466         3D BIOPRINTING MARKET: COMPONENT FOOTPRINT 369

11.5.5.3 Regional footprint              369

TABLE 467         3D BIOPRINTING MARKET: REGIONAL FOOTPRINT      369

11.5.5.4 Material footprint 370

TABLE 468         3D BIOPRINTING MARKET: MATERIAL FOOTPRINT       370

11.5.5.5 Application footprint         371

TABLE 469         3D BIOPRINTING MARKET: APPLICATION FOOTPRINT 371

11.6       COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023         371

11.6.1    PROGRESSIVE COMPANIES       371

11.6.2    RESPONSIVE COMPANIES          371

11.6.3    DYNAMIC COMPANIES 372

11.6.4    STARTING BLOCKS       372

FIGURE 38         3D BIOPRINTING MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023           372

11.6.5    COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023           373

TABLE 470         3D BIOPRINTING MARKET: DETAILED LIST OF KEY START-UPS/SMES         373

TABLE 471         3D BIOPRINTING MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES          374

11.7       VALUATION AND FINANCIAL METRICS 375

FIGURE 39         EV/EBITDA OF KEY VENDORS   375

FIGURE 40         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 375

11.8       BRAND/PRODUCT COMPARISON          376

FIGURE 41         3D BIOPRINTING MARKET: BRAND/PRODUCT COMPARISON              376

11.8.1    BICO GROUP AB             377

11.8.2    REGENHU         377

11.8.3    ROKIT HEALTHCARE, INC.         377

11.9       COMPETITIVE SCENARIO          377

11.9.1    PRODUCT LAUNCHES  377

TABLE 472         3D BIOPRINTING MARKET: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2024          377

11.9.2    DEALS  378

TABLE 473         3D BIOPRINTING MARKET: DEALS, JANUARY 2021–MARCH 2024              378

11.9.3    EXPANSIONS    379

TABLE 474         3D BIOPRINTING MARKET: EXPANSIONS, JANUARY 2021–MARCH 2024     379

11.9.4    OTHER DEVELOPMENTS           379

TABLE 475         3D BIOPRINTING MARKET: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2024          379

12          COMPANY PROFILES    380

(Business overview, Products/Solutions/Services offered, Recent developments & MnM View)*

12.1       KEY PLAYERS   380

12.1.1    BICO GROUP AB             380

TABLE 476         BICO GROUP AB: COMPANY OVERVIEW             380

FIGURE 42         BICO GROUP AB: COMPANY SNAPSHOT (2023) 381

TABLE 477         BICO GROUP AB: PRODUCTS/SERVICES/SOLUTIONS OFFERED              382

TABLE 478         BICO GROUP AB: PRODUCT LAUNCHES             389

TABLE 479         BICO GROUP AB: DEALS            390

TABLE 480         BICO GROUP AB: EXPANSIONS 392

TABLE 481         BICO GROUP AB: OTHER DEVELOPMENTS        392

12.1.2    3D SYSTEMS, INC.          393

TABLE 482         3D SYSTEMS, INC.: COMPANY OVERVIEW           393

FIGURE 43         3D SYSTEMS, INC.: COMPANY SNAPSHOT (2022)             394

TABLE 483         3D SYSTEMS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED          395

TABLE 484         3D SYSTEMS, INC.: DEALS          401

TABLE 485         3D SYSTEMS, INC.: EXPANSIONS             401

12.1.3    MERCK KGAA   403

TABLE 486         MERCK KGAA: COMPANY OVERVIEW    403

FIGURE 44         MERCK KGAA: COMPANY SNAPSHOT (2023)      404

TABLE 487         MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED              405

TABLE 488         MERCK KGAA: EXPANSIONS      409

12.1.4    ORGANOVO HOLDINGS INC.    410

TABLE 489         ORGANOVO HOLDINGS INC.: COMPANY OVERVIEW     410

FIGURE 45         ORGANOVO HOLDINGS INC.: COMPANY SNAPSHOT (2023)              411

TABLE 490         ORGANOVO HOLDINGS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED   411

TABLE 491         ORGANOVO HOLDINGS INC.: DEALS    412

12.1.5    COLLPLANT BIOTECHNOLOGIES LTD. 413

TABLE 492         COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY OVERVIEW              413

FIGURE 46         COLLPLANT BIOTECHNOLOGIES LTD.: COMPANY SNAPSHOT (2023)   414

TABLE 493         COLLPLANT BIOTECHNOLOGIES LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED   414

TABLE 494         COLLPLANT BIOTECHNOLOGIES LTD.: PIPELINE PRODUCTS/SERVICES/SOLUTIONS OFFERED   415

TABLE 495         COLLPLANT BIOTECHNOLOGIES LTD.: PRODUCT LAUNCHES              415

TABLE 496         COLLPLANT BIOTECHNOLOGIES LTD.: DEALS 416

12.1.6    REGENHU         417

TABLE 497         REGENHU: COMPANY OVERVIEW          417

TABLE 498         REGENHU: PRODUCTS/SERVICES/SOLUTIONS OFFERED              418

12.1.7    ASPECT BIOSYSTEMS LTD.        419

TABLE 499         ASPECT BIOSYSTEMS LTD.: COMPANY OVERVIEW         419

TABLE 500         ASPECT BIOSYSTEMS LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED   419

TABLE 501         ASPECT BIOSYSTEMS LTD.: DEALS        420

12.1.8    ADVANCED SOLUTIONS LIFE SCIENCES, LLC    421

TABLE 502         ADVANCED SOLUTIONS LIFE SCIENCES, LLC: COMPANY OVERVIEW        421

TABLE 503         ADVANCED SOLUTIONS LIFE SCIENCES, LLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED   421

TABLE 504         ADVANCED SOLUTIONS LIFE SCIENCES, LLC: DEALS    423

TABLE 505         ADVANCED SOLUTIONS LIFE SCIENCES, LLC: OTHER DEVELOPMENTS           423

12.1.9    CYFUSE BIOMEDICAL K.K.         424

TABLE 506         CYFUSE BIOMEDICAL K.K.: COMPANY OVERVIEW          424

TABLE 507         CYFUSE BIOMEDICAL K.K.: PRODUCTS/SERVICES/SOLUTIONS OFFERED          424

12.1.10  ROKIT HEALTHCARE, INC.         425

TABLE 508         ROKIT HEALTHCARE, INC.: COMPANY OVERVIEW         425

TABLE 509         ROKIT HEALTHCARE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED          426

12.1.11  HANGZHOU GENOFEI BIOTECHNOLOGY CO., LTD.      427

TABLE 510         HANGZHOU GENOFEI BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW  427

TABLE 511         HANGZHOU GENOFEI BIOTECHNOLOGY CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED   427

12.1.12  FOLDINK           430

TABLE 512         FOLDINK: COMPANY OVERVIEW           430

TABLE 513         FOLDINK: PRODUCTS/SERVICES/SOLUTIONS OFFERED              430

12.1.13  BRINTER            432

TABLE 514         BRINTER: COMPANY OVERVIEW            432

TABLE 515         BRINTER: PRODUCTS/SERVICES/SOLUTIONS OFFERED              432

TABLE 516         BRINTER: DEALS            434

TABLE 517         BRINTER: EXPANSIONS 435

12.1.14  3D BIOPRINTING SOLUTIONS   436

TABLE 518         3D BIOPRINTING SOLUTIONS: COMPANY OVERVIEW   436

TABLE 519         3D BIOPRINTING SOLUTIONS: PRODUCTS/SERVICES/SOLUTIONS OFFERED   436

*Details on Business overview, Products/Solutions/Services offered, Recent developments & MnM View might not be captured in case of unlisted companies.

12.2       OTHER PLAYERS           437

12.2.1    REGEMAT 3D, SL            437

TABLE 520         REGEMAT 3D, SL: COMPANY OVERVIEW            437

12.2.2    ΡΟΙΕTIS        438

TABLE 521         POIETIS: COMPANY OVERVIEW 438

12.2.3    SUNP BIOTECH 439

TABLE 522         SUNP BIOTECH: COMPANY OVERVIEW 439

12.2.4    GESIM–GESELLSCHAFT FÜR SILIZIUM-MIKROSYSTEME MBH    440

TABLE 523         GESIM–GESELLSCHAFT FÜR SILIZIUM-MIKROSYSTEME MBH: COMPANY OVERVIEW  440

12.2.5    MEDPRIN          441

TABLE 524         MEDPRIN: COMPANY OVERVIEW           441

12.2.6    VOXCELL BIOINNOVATION INC.            441

TABLE 525         VOXCELL BIOINNOVATION INC.: COMPANY OVERVIEW              441

12.2.7    PRODWAYS       442

TABLE 526         PRODWAYS: COMPANY OVERVIEW       442

12.2.8    INVENTIA LIFE SCIENCE PTY LTD.         442

TABLE 527         INVENTIA LIFE SCIENCE PTY LTD.: COMPANY OVERVIEW              442

12.2.9    UPNANO GMBH             443

TABLE 528         UPNANO GMBH: COMPANY OVERVIEW 443

12.2.10  UPM     444

TABLE 529         UPM: COMPANY OVERVIEW      444

12.2.11  TISSUELABS      445

TABLE 530         TISSUELABS: COMPANY OVERVIEW      445

13          APPENDIX         446

13.1       DISCUSSION GUIDE      446

13.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             450

13.3       CUSTOMIZATION OPTIONS      452

13.4       RELATED REPORTS       452

13.5       AUTHOR DETAILS         453